Skip to main content
Subscribe
Register
Sign in
Membership
Insights
Events
About
Subscribe
Register
Sign in
Premium
Alternative Insight and Premium Journalism
Latest Articles
Premium
EcoR1 Makes a Timely Bet
Stephen Taub
October 16, 2023
Premium
The Tiger Crowd Sagged in September
Stephen Taub
October 12, 2023
Premium
Amid a Rough Year for Life Sciences, Cormorant Delivers Healthy Returns
Stephen Taub
October 11, 2023
Premium
Why Most of AQR’s Largest Strategies Rose Sharply in September
Stephen Taub
October 10, 2023
Premium
Third Point Doubles Its Short Positions
Stephen Taub
October 9, 2023
Premium
Hedge Funds Sharply Curtail Private Investments
Stephen Taub
October 4, 2023
Premium
Hedge Fund Faves Outperform in 3Q
Stephen Taub
October 3, 2023
Premium
D.E. Shaw Settles Civil Charges With the SEC
Stephen Taub
October 2, 2023
Premium
Greenlight Up Sharply in September
Stephen Taub
October 2, 2023
Premium
The Hedge Fund Winners From Immunovant’s Rise
Stephen Taub
September 28, 2023
Premium
Here’s Why Michael Bilger’s 59 North Has Been One of the Top Launches in Recent Years
Stephen Taub
September 27, 2023
Premium
Why a Hedge Fund Is Betting on This Groupon Deal
Stephen Taub
September 26, 2023
Premium
Hedge Funds Sidestep IPO Disasters
Stephen Taub
September 25, 2023
Premium
Here’s Sosin’s Latest Win
Stephen Taub
September 21, 2023
Premium
RA Capital Is Prepping New VC Fund
Stephen Taub
September 20, 2023
Premium
Life Sciences Funds Suffer Losses Last Month
Stephen Taub
September 19, 2023
Premium
Cadian Is Back at the Top
Stephen Taub
September 18, 2023
Premium
Most Descendants of Tiger Management Are Far From Recovering Their High Water Marks
Stephen Taub
September 14, 2023
More Articles